Dr. Moy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Blossom St
Cox 1
Boston, MA 02114Phone+1 617-724-4800Fax+1 617-724-1684
Education & Training
Brigham and Women's HospitalInternship, Internal Medicine, 1996 - 1997
Albert Einstein College of MedicineClass of 1996
Certifications & Licensure
MA State Medical License 1998 - 2025
NH State Medical License 2024 - 2024
ME State Medical License 2020 - 2021- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow of the American Society of Clinical Oncology American Society of Clinical Oncology, 2018
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- The Hurria Older PatiEnts (HOPE) With Breast Cancer Study Start of enrollment: 2011 Sep 09
- HKI-272 for HER2-Positive Breast Cancer and Brain Metastases Start of enrollment: 2012 Feb 01
Publications & Presentations
PubMed
- 109 citationsTroponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and LapatinibPatrick G. Morris, Carol L. Chen, Richard M. Steingart, Martin Fleisher, Nan Lin
Clinical Cancer Research. 2011-05-15 - 21 citationsTEACH: Tykerb evaluation after chemotherapy.Beverly Moy, Paul E. Goss
Clinical Breast Cancer. 2007-02-01 - 104 citationsLapatinib: Current Status and Future Directions in Breast CancerBeverly Moy, Paul E. Goss
The Oncologist. 2006-11-01
Other
- Surveillance after colorectal cancer resectionMoy B, Jacobson BC, Farraye FA
http://www.uptodate.com/contents/surveillance-after-colorectal-cancer-resection
UpToDate, Wolters Kluwer Health - 2013-03-28 - Cystitis in patients with cancerMoy B
http://www.uptodate.com/contents/cystitis-in-patients-with-cancer
UpToDate, Wolters Kluwer Health - 2012-11-30
Press Mentions
A Massachusetts Mother Shares Her Breast Cancer Treatment Journey - and Hope for the FutureMarch 26th, 2022- Puma Biotechnology Presents Data from the Phase III ExteNET Trial in Early Stage HER2-Positive Breast Cancer Patients at the Virtual 2021 ASCO Annual MeetingJune 4th, 2021
- Boston Medical Center, Dana-Farber Cancer Institute, Massachusetts General Hospital Formalize Cancer Clinical Trial CollaborationSeptember 29th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
